Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphomaNozomi Niitsu, Yoshio Honma, Masami Hirano et al.|Blood|2001Cited by 74
Sensitization by 5‐aza‐2′‐deoxycytidine of leukaemia cells with <i>MLL</i> abnormalities to induction of differentiation by all‐<i>trans</i> retinoic acid and 1α,25‐dihydroxyvitamin D<sub>3</sub>Nozomi Niitsu, Yoshio Honma, Kanji Sugita et al.|British Journal of Haematology|2001Cited by 69
Prognostic Implications of the Differentiation Inhibitory Factornm23-H1 Protein in the Plasma of Aggressive Non-Hodgkin’s LymphomaNozomi Niitsu, Yoshio Honma, Junko Okabe‐Kado et al.|Blood|1999Cited by 47
Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemiaNozomi Niitsu, Yoshio Honma, Junko Okabe‐Kado et al.|Blood|2000Cited by 42
Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemiaNozomi Niitsu, Yoshio Honma, Junko Okabe‐Kado et al.|Blood|2000Cited by 41